We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Custom Designed Microarrays Give Genomics Researchers Greater Flexibility

By LabMedica International staff writers
Posted on 02 Jun 2011
Genomics researchers can now order custom designed microarray plates that will allow them to evaluate samples with from 1,500 to 2.6 million markers.

The new Axiom myDesign Targeted Genotyping (TG) Arrays are a product of Affymetrix, Inc. More...
(Santa Clara, CA, USA). While Affymetrix encourages investigators to submit markers, many will prefer to depend on the well-characterized markers available in the Axiom Genomic Data Base.

The Axiom Genomic Database, with 11 million rare and common variants with minor allele frequency (MAF) greater than 1%, is derived from sources such as NHGRI, the International HapMap, and 1000 Genomes Project. Each marker is annotated by MAF, linkage disequilibrium (LD), and haplotype information, as well as SNP (single nucleotide polymorphism) classification and biological function. The database also contains approximately four million SNPs associated with key processes or pathways important to the study of pharmacogenomics genes, cardiovascular disease, the human leukocyte antigen (HLA) region, and inflammatory and immunity disease, as well as genes from the Sanger Cancer Gene Census and previous association studies.

Affymetrix has rendered the custom design process much simpler by creating the Axiom Design Center, an easy-to-use, web-based tool in that enables the researcher to quickly select markers from the Axiom Genomic Database and design the custom array. The Axiom Design Center provides access to markers based on gene symbol, chromosome, region, locus ID, biological category, or from previous commercial microarrays, including Affymetrix and others.

"Axiom myDesign TG Arrays will help researchers to quickly evaluate interesting variants from their GWAS (genome wide association study), sequencing, and candidate gene initiatives without limiting the number of markers in their study," said Andy Last, Chief Commercial Officer of Affymetrix. "Customers who want to add newly discovered content after they complete the initial design can benefit from our new flexible content capability without switching platforms."

Related Links:

Affymetrix, Inc.




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
New
Portable POCT Blood Gas Analyzer
BD100
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.